ARTICLE | Company News
EC approves Takeda's Edarbi
December 10, 2011 1:26 AM UTC
The European Commission approved Edarbi azilsartan medoxomil from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to treat hypertension. Takeda plans to launch the once-daily angiotensin II type 1 (AT1) r...